Sandoz Tofacitinib 5 mg (Tofacitinib (Tofacitinib Citrate) TABLET) 5 MG

Sandoz Tofacitinib 5 mg tablets are a medication used to manage specific inflammatory conditions. This oral treatment is designed to help alleviate symptoms and improve quality of life for those with qualifying conditions.

Strength

5 MG

Manufacturer / TM Owner

SANDOZ CANADA INCORPORATED

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Tofacitinib, also known as tofacitinib citrate, is primarily used for the treatment of inflammatory conditions such as rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis. This medication works by modulating the immune system to reduce inflammation and associated symptoms. Patients often wonder, 'What is tofacitinib used for?' and the answer lies in its ability to target specific pathways involved in these chronic conditions.

Side Effects

Common effects of tofacitinib may include mild to moderate side effects such as headaches, nausea, and upper respiratory infections. Some users may also experience fatigue or changes in blood cell counts. It's important to monitor for any unusual symptoms and consult a healthcare provider if concerns arise.

Precautions & Warnings

Tofacitinib should be handled with care, especially for individuals with a history of infections or blood disorders. Regular monitoring may be necessary to ensure safety and efficacy. Always follow the guidance of a healthcare professional when using this medication.

Avoid Interactions

Tofacitinib may interact with certain medications, including those that affect the immune system or blood cell production. It's important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Additionally, alcohol consumption should be discussed with a healthcare provider.

Frequently Asked Questions

Tofacitinib is used to manage inflammatory conditions such as rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis.

Tofacitinib tablets are taken orally, typically once or twice daily as directed by a healthcare provider.

Common side effects may include headaches, nausea, upper respiratory infections, and fatigue.

Consult your healthcare provider regarding alcohol consumption while taking tofacitinib.

Long-term use of tofacitinib should be monitored by a healthcare provider to ensure safety and efficacy.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.